pipette
ESEspañol

Pulsed Field Ablation for Persistent Atrial Fibrillation

Peer-reviewed journalReal-world use

In the authors' words

This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.

Main result
To the Editor: In the AVANT GUARD trial, Wazni et al. (June 25 issue) 1 report that pulsed field ablation (PFA) was superior to antiarrhythmic drugs as the initial treatment for persistent atrial fibrillation (hazard ratio for composite treatment failure, 0.46).
Limitation the authors admit
The trial was paused after six procedure-related strokes occurred.

Appeared: Friday, October 23. New England Journal of Medicine. Peer-reviewed journal.

DOI: 10.1056/nejmc2610073